Sola Diagnostics GmbH logo โ€” The WIDยฎ-easy Test - Now also available in Switzerland ๐Ÿ‡จ๐Ÿ‡ญ
๐Ÿ‘‰...

Sola Diagnostics GmbH

The WIDยฎ-easy Test - Now also available in Switzerland ๐Ÿ‡จ๐Ÿ‡ญ ๐Ÿ‘‰ Unnecessary hysteroscopy and curettage can be avoided

Founded 2020 Austria Austria 2 employees Seed Total: $2.39M Biotechnology, Health Care

General Information

Company Name Sola Diagnostics GmbH
Founded Year 2020
Location Austria Austria +1
Employees 2
Industries Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when Sola Diagnostics GmbH moves

Funding, new markets, leadership changes, hiring surges โ€” one e-mail, only when something happens.

Free ยท no account needed

About Sola Diagnostics GmbH

Sola Diagnostics GmbH is a biotechnology and healthcare startup which is the home of the WIDยฎ-Test. Founded in 2020 and headquartered in Austria, the company has recently secured a โ‚ฌ400.00K Seed Round investment from FPS-Holding on 20 February 2025. Their slogan "The WIDยฎ-easy Test - Now also available in Switzerland" highlights the expansion of their innovative product, emphasizing its potential to prevent unnecessary hysteroscopy and curettage. This recent investment reflects investor confidence in Sola Diagnostics GmbH's vision and the promising future of their groundbreaking diagnostic technology.

Taxonomy: women's health diagnostics, epigenetic testing, gynecological diagnostics, DNA methylation, PCR-based analysis, clinical validation, first-line diagnostic, non-invasive testing, cancer detection, startup expansion, private equity investment

Services & Products

Developing and providing epigenetic diagnostic tests for gynecological cancer detection

Target Customers

Patients healthcare providers and laboratories

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round โ€ขโ€ขโ€ขโ€ขโ€ขโ€ข 1 โ€ขโ€ขโ€ขโ€ข โ€ขโ€ขโ€ขโ€ข 20 Feb 2025
Seed Round โ€ขโ€ขโ€ขโ€ขโ€ขโ€ข 1 โ€ขโ€ขโ€ขโ€ข โ€ขโ€ขโ€ขโ€ข 24 Jun 2024
Seed Round โ€ขโ€ขโ€ขโ€ขโ€ขโ€ข - 11 Mar 2022
Pre Seed Round โ€ขโ€ขโ€ขโ€ขโ€ขโ€ข - 30 Sep 2021
Pre Seed Round โ€ขโ€ขโ€ขโ€ขโ€ขโ€ข - 29 May 2020

Sola Diagnostics GmbH Alternatives & Competitors

Sola Diagnostics GmbH vs
UT MD Anderson
UT MD Anderson United States

MD Anderson is a global leader in cancer care, research, education and training, and prevention. Our...

Grant
23099 employees
Health Care
Sola Diagnostics GmbH vs
The WISDOM Study
The WISDOM Study United States

A nationwide breast cancer screening and prevention trial. See our participants' stories in TIME: ht...

9 employees
Sola Diagnostics GmbH vs

We are an Alternative Cancer Education Clinic offering resources to those with Cancer, Chronic Lyme,...

4 employees
Health Care, Health and Wellness

FAQ About Sola Diagnostics GmbH

The WIDยฎ-easy Test - Now also available in Switzerland ๐Ÿ‡จ๐Ÿ‡ญ ๐Ÿ‘‰ Unnecessary hysteroscopy and curettage can be avoided
Sola Diagnostics GmbH was founded in 2020.
Sola Diagnostics GmbH is headquartered in Austria.
Sola Diagnostics GmbH operates in the following industries: Biotechnology, Health Care.
Sola Diagnostics GmbH has approximately 2 employees.
Sola Diagnostics GmbH has completed 5 funding rounds, raising a total of $2.39M. The latest funding stage is Seed.
Sola Diagnostics GmbH offers: Developing and providing epigenetic diagnostic tests for gynecological cancer detection.
Top alternatives and competitors to Sola Diagnostics GmbH include UT MD Anderson, The WISDOM Study, Conners Clinic, Cancer Center for Healing, UNC Lineberger Comprehensive Cancer Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sola Diagnostics GmbH and UT MD Anderson are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sola Diagnostics GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types โ€” so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy